P Dobrocký

Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.

LJ Notarianni, SE Oliver, P Dobrocký et al. · British Journal of Clinical Pharmacology · 1995 · 38 citations · Full text

Metabolomic Profiling, Physiologically-based Pharmacokinetic Modeling, Molecular Pharmacology +23

Rapid method for the routine determination of caffeine and its metabolites by high-performance liquid chromatography

P Dobrocký, Peter N. Bennett, Lidia J. Notarianni · Journal of Chromatography B Biomedical Sciences and Applications · 1994 · 28 citations

Medicine, Bioanalysis, Analytical Chemistry +8

Endothelial changes following repeated effect of vasoconstrictive substances in vitro.

Kristová, M Kriska, R Canová et al. · PubMed · 1993 · 22 citations

Heart Failure, Ear Arteries, Cardiology +17

Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.

A D Spigelman, K. Chip Farmer, Sandy Oliver et al. · Gut · 1995 · 19 citations · Full text

Familial Adenomatous Polyposis, Medicine, Lipid Peroxidation +11

Caffeine as a metabolic probe: NAT2 phenotyping

Lidia J. Notarianni, P Dobrocký, Grzegorz Godlewski et al. · British Journal of Clinical Pharmacology · 1996 · 12 citations